NINJ1 and Posterior Leukoencephalopathy Syndrome: The identification of NINJ1 as a prognostic factor represents a significant advance in the management of RPLS, with the potential to guide treatment decisions, improve patient outcomes, and inspire the development of novel targeted drugs.